Have a personal or library account? Click to login
Are exercise-induced changes of fatty acids associated with cardiac hypertrophy in athletes? A pilot study Cover

Are exercise-induced changes of fatty acids associated with cardiac hypertrophy in athletes? A pilot study

Open Access
|Sep 2021

References

  1. 1. Børsheim E., Knardahl S., Høstmark A. T. (1999) Short-term effects of exercise on plasma very low density lipo-proteins (VLDL) and fatty acids. Med. Sci. Sports Exerc., 31(4): 522-530.10.1097/00005768-199904000-00005
  2. 2. Chrysohoou C., Metallinos G., Georgiopoulos G., Mendrinos D., Papanikolaou A., Magkas N., Pitsavos C., Vyssoulis G., Stefanadis C., Tousoulis D. (2016) Short term omega-3 polyunsaturated fatty acid supplementation induces favorable changes in right ventricle function and diastolic filling pressure in patients with chronic heart failure; A randomized clinical trial. Vascul. Pharmacol., 79: 43-50.10.1016/j.vph.2016.01.005
  3. 3. Conquer J.A., Roelfsema H., Zecevic J., Graham T.E., and Holub B.J. (2002) Effect of exercise on FA profiles in n-3 FA-supplemented and nonsupplemented premenopausal women. Lipids, 37(10): 947-951. DOI: 10.1007/s11745-006-0985-0.10.1007/s11745-006-0985-0
  4. 4. Cunha R.M., Arsa G., Neves E.B., Lopes L.C., Santana F., Noleto M.V., Rolim T.I., Lehnen A.M. (2016) Water aerobics is followed by short-time and immediate systolic blood pressure reduction in overweight and obese hypertensive women. J. Am. Soc. Hypertens., 10(7): 570-577.10.1016/j.jash.2016.05.002
  5. 5. De Caterina R. Basta G. (2001) n-3 Fatty acids and the inflammatory response – biological background. Eur. Heart J. Suppl., 3(suppl_D): D42-D49.10.1016/S1520-765X(01)90118-X
  6. 6. De Las Fuentes L., Soto P.F., Cupps B.P., Pasque M.K., Herrero P., Gropler R.J., Waggoner A.D., Dávila-Román V.G. (2006) Hypertensive left ventricular hyper-trophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency. J. Nucl. Cardiol., 13(3): 369-377.10.1016/j.nuclcard.2006.01.021
  7. 7. Devereux R.B. Reichek N. (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation, 55(4): p. 613-618.10.1161/01.CIR.55.4.613
  8. 8. Duda M.K., O’Shea K.M., Lei B., Barrows B.R., Azimzadeh A.M., McElfresh T.E., Hoit B.D., Kop W.J., Stanley W.C. (2007) Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc. Res., 76(2): 303-310. DOI: 10.1016/j. cardiores.2007.07.002.10.1016/j.cardiores.2007.07.002
  9. 9. Evangelista F., Brum P., Krieger J. (2003) Duration-controlled swimming exercise training induces cardiac hypertrophy in mice. Braz. J. Med. Biol. Res., 36(12): 1751-1759.10.1590/S0100-879X2003001200018
  10. 10. Ghule A.E., Kandhare A.D., Jadhav S.S., Zanwar A.A., Bodhankar S.L. (2015) Omega-3-fatty acid adds to the protective effect of flax lignan concentrate in pressure overload-induced myocardial hypertrophy in rats via modulation of oxidative stress and apoptosis. Int. Immunopharmacol., 28(1): 751-763. DOI: 10.1016/j. intimp.2015.08.005.10.1016/j.intimp.2015.08.005
  11. 11. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., White M.F., Shulman G.I. (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes, 48(6): 1270-1274.10.2337/diabetes.48.6.1270
  12. 12. Horowitz J.F. (2003) Fatty acid mobilization from adi-pose tissue during exercise. Trends Endocrinol. Metab., 14(8): 386-392. DOI: 10.1016/s1043-2760(03)00143-7.10.1016/S1043-2760(03)00143-7
  13. 13. Ismail H.M. (2005) The role of omega-3 fatty acids in cardiac protection: an overview. Front. Biosci., 10: 1079-1088.10.2741/1601
  14. 14. Itani S.I., Ruderman N.B., Schmieder F., Boden G. (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes, 51(7): 2005-2011.10.2337/diabetes.51.7.200512086926
  15. 15. Itoh M., Suganami T., Satoh N., Tanimoto-Koyama K., Yuan X., Tanaka M., Kawano H., Yano T., Aoe S., Takeya M. (2007) Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler. Thromb. Vasc. Biol., 27(9): p. 1918-1925.10.1161/ATVBAHA.106.13685317569885
  16. 16. Jalili T., Manning J., and Kim S. (2003) Increased trans-location of cardiac protein kinase C β2 accompanies mild cardiac hypertrophy in rats fed saturated fat. J. Nutr., 133(2): 358-361.10.1093/jn/133.2.35812566467
  17. 17. Kim O.Y., Jung Y.S., Cho Y., Chung J.H., Hwang G.S., Shin M.J. (2013) Altered heart and kidney phospholipid fatty acid composition are associated with cardiac hypertrophy in hypertensive rats. Clin. Biochem., 46(12): 1111-1117. DOI: 10.1016/j.clinbiochem.2013.04.008.10.1016/j.clinbiochem.2013.04.00823608354
  18. 18. Lennie T.A., Chung M.L., Habash D.L., Moser D.K. (2005) Dietary fat intake and proinflammatory cytokine levels in patients with heart failure. J. Card. Fail., 11(8): 613-618.10.1016/j.cardfail.2005.06.43416230265
  19. 19. Lundgrin E.L., Park M.M., Sharp J., Tang W.H., Thomas J.D., Asosingh K., Comhair S.A., DiFilippo F.P., Neumann D.R., Davis L., Graham B.B., Tuder R.M., Dostanic I., Erzurum S.C. (2013) Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year. Ann. Am. Thorac. Soc., 10(1): 1-9. DOI: 10.1513/AnnalsATS.201206-029OC.10.1513/AnnalsATS.201206-029OC396099123509326
  20. 20. Morgan D.R., Dixon L.J., Hanratty C.G., El-Sherbeeny N., Hamilton P.B., McGrath L.T., Leahey W.J., Johnston G.D., McVeigh G.E. (2006) Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure. Am. J. Cardiol., 97(4): 547-551.10.1016/j.amjcard.2005.08.07516461054
  21. 21. Mougios V., Kouidi E., Kyparos A., Deligiannis A. (1998) Effect of exercise on the proportion of unsaturated fatty acids in serum of untrained middle aged individuals. Br. J. Sports Med., 32(1): 58-62.10.1136/bjsm.32.1.5817560569562166
  22. 22. Mozaffarian D., Appel L.J., Van Horn L. (2011) Components of a cardioprotective diet: new insights. Circulation, 123(24): 2870-2891. DOI: 10.1161/CIRCULATIONAHA.110.968735.10.1161/CIRCULATIONAHA.110.968735626129021690503
  23. 23. Neri Serneri G.G., Boddi M., Modesti P.A., Cecioni I., Coppo M., Padeletti L., Michelucci A., Colella A., Galanti G. (2001) Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ. Res., 89(11): 977-982.10.1161/hh2301.10098211717153
  24. 24. Neschen S., Morino K., Rossbacher J.C., Pongratz R.L., Cline G.W., Sono S., Gillum M., Shulman G.I. (2006) Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-γ-dependent mechanism in mice. Diabetes, 55(4): 924-928.10.2337/diabetes.55.04.06.db05-098516567512
  25. 25. Nguyen S., Shao D., Tomasi L.C., Braun A., de Mattos A.B.M., Choi Y.S., Villet O., Roe N., Halterman C.R., Tian R., Kolwicz S.C., Jr. (2017) The effects of fatty acid composition on cardiac hypertrophy and function in mouse models of diet-induced obesity. J. Nutr. Biochem., 46: 137-142. DOI: 10.1016/j.jnutbio.2017.05.009.10.1016/j.jnutbio.2017.05.009551695028605665
  26. 26. Nikolaidis M.G. Mougios V. (2004) Effects of exercise on the fatty-acid composition of blood and tissue lipids. Sports Med., 34(15): 1051-1076.10.2165/00007256-200434150-0000415575795
  27. 27. Nilsson J., Ericsson M., Joibari M.M., Anderson F., Carlsson L., Nilsson S.K., Sjödin A., Burén J. (2016) A low-carbohydrate high-fat diet decreases lean mass and impairs cardiac function in pair-fed female C57BL/6J mice. Nutr. Metab. (Lond.), 13(1): 1-12.10.1186/s12986-016-0132-8511123827891164
  28. 28. Pepe S. McLennan P.L. (2007) (n-3) Long chain PUFA dose-dependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats. J. Nutr., 137(11): 2377-2383.10.1093/jn/137.11.237717951473
  29. 29. Rahimi S., Khademvatani K., Zolfaghari M.R. (2018) Association of circular Klotho and insulin-like growth factor 1 with cardiac hypertrophy indexes in athlete and non-athlete women following acute and chronic exercise. Biochem. Biophys. Res. Commun., 505(2): 448-452.10.1016/j.bbrc.2018.09.13830269819
  30. 30. Rupp H., Rupp T.P., Alter P., Maisch B. (2010) Inverse shift in serum polyunsaturated and monounsaturated fatty acids is associated with adverse dilatation of the heart. Heart, 96(8): 595-598.10.1136/hrt.2009.17656019723686
  31. 31. Rupp H., Rupp T.P., Wagner D., Alter P., Maisch B. (2006) Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the “EPA+ DHA level”. Cardiovascular Benefits of Omega-3 Polyunsaturated Fatty Acids. IOS Press, Amsterdam: p. 47-79.
  32. 32. Russo S.B., Baicu C.F., Van Laer A., Geng T., Kasiganesan H., Zile M.R., Cowart L.A. (2012) Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes. J. Clin. Investig., 122(11): 3919-3930.10.1172/JCI63888348444823023704
  33. 33. Serneri G.G., Modesti P.A., Boddi M., Cecioni I., Paniccia R., Coppo M., Galanti G., Simonetti I., Vanni S., Papa L., Bandinelli B., Migliorini A., Modesti A., Maccherini M., Sani G., Toscano M. (1999) Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ. Res., 85(1): 57-67. DOI: 10.1161/01.res.85.1.57.10.1161/01.RES.85.1.5710400911
  34. 34. Shei R.-J., Lindley M.R., Mickleborough T.D. (2014) Omega-3 polyunsaturated fatty acids in the optimization of physical performance. Mil. Med., 179(suppl_11): 144-156.10.7205/MILMED-D-14-00160
  35. 35. Shimizu I. Minamino T. (2016) Physiological and pathological cardiac hypertrophy. J. Mol. Cell. Cardiol., 97: 245-262. DOI: 10.1016/j.yjmcc.2016.06.001.10.1016/j.yjmcc.2016.06.00127262674
  36. 36. Shimizu I. Minamino T. (2016) Physiological and pathological cardiac hypertrophy. J. Mol. Cell. Cardiol., 97: 245-262.10.1016/j.yjmcc.2016.06.001
  37. 37. Shudo Y., Taniguchi K., Takeda K., Sakaguchi T., Matsue H., Izutani H., Matsumiya G., Sawa Y. (2010) Assessment of regional myocardial wall stress before and after surgical correction of functional ischaemic mitral regurgitation using multidetector computed tomography and novel software system. Eur. J. Cardiothorac. Surg., 38(2): 163-170.10.1016/j.ejcts.2010.01.02920619218
  38. 38. Siddiqui R.A., Shaikh S.R., Kovacs R., Stillwell W., Zaloga G. (2004) Inhibition of phenylephrine-induced cardiac hypertrophy by docosahexaenoic acid. J. Cell. Biochem., 92(6): 1141-1159.10.1002/jcb.20135
  39. 39. Stebbins C.L., Maruoka Y., Longhurst J.C. (1986) Pros-taglandins contribute to cardiovascular reflexes evoked by static muscular contraction. Circ. Res., 59(6): 645-654.10.1161/01.RES.59.6.645
  40. 40. Sundström J., Lind L., Vessby B., Andrén B., Aro A., Lithell H.O. (2001) Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation, 103(6): 836-841.10.1161/01.CIR.103.6.836
  41. 41. Takahashi R., Okumura K., Asai T., Hirai T., Murakami H., Murakami R., Numaguchi Y., Matsui H., Ito M., and Murohara T. (2005) Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc. Res., 68(2): p. 213-223.10.1016/j.cardiores.2005.05.018
  42. 42. Tepsic J., Vucic V., Arsic A., Blazencic-Mladenovic V., Mazic S., Glibetic M. (2009) Plasma and erythrocyte phospholipid fatty acid profile in professional basketball and football players. Eur. J. Appl. Physiol., 107(3): 359-365.10.1007/s00421-009-1131-5
  43. 43. van der Vusse G.J., van Bilsen M., Glatz J.F. (2000) Cardiac fatty acid uptake and transport in health and disease. Cardiovasc. Res., 45(2): 279-293.10.1016/S0008-6363(99)00263-1
  44. 44. Whyte G., George K., Sharma S., Firoozi S., Stephens N., Senior R., McKenna W. (2004) The upper limit of physiological cardiac hypertrophy in elite male and female athletes: the British experience. Eur. J. Appl. Physiol., 92(4): 592-597.10.1007/s00421-004-1052-215054661
  45. 45. Wilson J.R. Kapoor S.C. (1993) Contribution of pros-taglandins to exercise-induced vasodilation in humans. Am. J. Physiol., 265(1 Pt 2): p. H171-5. DOI: 10.1152/ajpheart.1993.265.1.H171.10.1152/ajpheart.1993.265.1.H1718342631
  46. 46. Yilmaz D.C., Buyukakilli B., Gurgul S., Rencuzogullari I. (2013) Adaptation of heart to training: a comparative study using echocardiography & impedance cardiography in male & female athletes. Indian J. Med. Res., 137(6): 1111.
  47. 47. Zechner R., Strauss J.G., Haemmerle G., Lass A., Zimmermann R. (2005) Lipolysis: pathway under construction. Curr. Opin. Lipidol., 16(3): 333-340.10.1097/01.mol.0000169354.20395.1c15891395
  48. 48. Zhou L.-Y., Liu J.-P., Wang K., Gao J., Ding S.-L., Jiao J.-Q., Li P.-F. (2013) Mitochondrial function in cardiac hypertrophy. Int. J. Cardiol., 167(4): 1118-1125.10.1016/j.ijcard.2012.09.082
Language: English
Page range: 237 - 245
Submitted on: Dec 18, 2020
Accepted on: May 18, 2021
Published on: Sep 20, 2021
Published by: University of Physical Education in Warsaw
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Ensiyeh Abdollahi, Saba Nikanfar, Mohammad Reza Zolfaghari, Amir Fattahi, published by University of Physical Education in Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.